SPECIAL NOTICE
99 -- NCI OA Special Notice of Subcontract Opportunity at the Frederick National Laboratory for Cancer Research: 1. Sources Sought Notice for potential clinical research sites to conduct a SARS CoV-2 clinical trial
- Notice Date
- 9/16/2020 12:41:17 PM
- Notice Type
- Special Notice
- NAICS
- 541990
— All Other Professional, Scientific, and Technical Services
- Contracting Office
- NIH National Cancer Institute Rockville MD 20850 USA
- ZIP Code
- 20850
- Response Due
- 9/18/2020 11:00:00 AM
- Archive Date
- 10/03/2020
- Point of Contact
- maureen wilson
- E-Mail Address
-
maureen.wilson2@nih.gov
(maureen.wilson2@nih.gov)
- Description
- Sources Sought Notice for potential clinical research sites to conduct a SARS CoV-2 clinical trial in support of the National Institute of Allergy and Infectious Diseases (NIAID) Division of Clinical Research (DCR). THIS IS A SOURCES SOUGHT NOTICE ONLY. THIS IS NOT A REQUEST FOR PROPOSAL. The FNLCR is a Government-Owned Contractor-Operated (GOCO) Federally Funded Research and Development Center (FFRDC) located at Fort Detrick, Maryland. The FNLCR partners with university, government, and corporate scientists to speed the translation of laboratory research into new diagnostic tests and treatments for cancer and AIDS. FNLCR is a multi-program laboratory currently operated by Leidos Biomedical Research Inc. (Leidos Biomed) for the National Cancer Institute (NCI) under Prime Contract No. 75N91019D00024, which provides Operations and Technical Support (OTS) for the Frederick National Lab. The Government assumes no liability for reimbursement for any effort or associated costs to respond, nor for any information provided as a result of this notice as no information is being requested. Please be advised that any submissions provided despite the aforementioned notice that no information is requested become Government property and will not be returned, nor will there be any ensuing discussions or debriefings of any responses. Responses submitted to this notice are not offers and cannot be accepted by the U.S. Government to form a binding contract. It is the responsibility of the interested parties to monitor this site and any sites referenced herein for additional information pertaining to business opportunities with the FNLCR, if any. Description of Work:� Leidos Biomed is in search of experienced, US-based, clinical research sites to participate in the NIH/NIAID-sponsored protocol, titled �Inpatient Treatment with Anti-Coronavirus Immunoglobulin� (ITAC).� Ideal sites would have the capacity to conduct inpatient COVID-19 investigational research.� Leidos Biomedical Research, Inc.� POC: If you are interested in obtaining the Request for Information, please contact Maureen Wilson, Sr. Subcontracts Administrator at maureen.wilson2@nih.gov �� For information concerning other opportunities with the FNLCR, please refer to: https://frederick.cancer.gov/workwithus/solicitations
- Web Link
-
SAM.gov Permalink
(https://beta.sam.gov/opp/00321d09282243d38bcb7f6cbc9bbc33/view)
- Record
- SN05799300-F 20200918/200916230158 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |